Dimethyl 1,3-Benzodithiol-2-ylphosphonate>98.0%(GC)1g

(2E)-1-(3-methoxyphenyl)-3-(thiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

3-(4-Benzyloxyphenyl)pentanedioic acid, 80.0%, 1g

(3R,4R)-3-methyl-4-(trifluoromethyl)pyrrolidine hydrochloride, 98%, 100mg

2-(4-Bromophenyl)oxazole, 95.0%, 25g

Bicyclo[2.2.1]heptan-1-ol, 97%, 50mg

Boc-L-b-homopropargylglycine, 98.0%, 250mg

2-Cyano-n-[(4-methoxyphenyl)methyl]acetamide, 97%, 250mg

Diethyl (S)-(2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate, 98%, 100mg

(2-Phenylpyrimidin-5-yl)methanol, 98%, 5g

2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate, 95.0%, 250mg

6-Fluoronaphthalen-1-amine, 98%, 250mg

HSA-Gb31vial